RecordLens

Claim review. Bribery

Supported

The cited record supports the material proposition.

The US Justice Department said in March 2016 that Olympus Corp. of the Americas would pay US$623.2 million to resolve kickback charges and claims, and that its Latin America unit would pay US$22.8 million over foreign bribery.

About
Olympus Corporation
Claim made by
US Department of Justice, regulator statement
Published
1 March 2016
Original
Medical Equipment Company Will Pay $646 Million for Making Illegal Payments to Doctors and Hospitals in United States and Latin America
Evidence score
82 How it was scored
Last reviewed
25 October 2026

Why this label

The department's release states that the US distributor was charged by complaint in Newark with conspiracy to violate the Anti-Kickback Statute and entered a three-year deferred prosecution agreementS8. It paid a US$312.4 million criminal penalty and US$310.8 million to settle False Claims Act claimsS8. The Miami-based Latin America unit was charged under the FCPA, entered its own three-year agreement and paid US$22.8 millionS8. The release says that unit admitted bribing publicly employed health care providersS8. A deferred prosecution agreement is not a conviction. The agreements bind the US subsidiaries, not the Tokyo parent. This review did not read later filings on how the agreements ended.

Current procedural position

Two three-year deferred prosecution agreements announced on 1 March 2016 in the District of New Jersey, with a civil False Claims Act settlementS8. No conviction. Later disposition not reviewed.

Record supporting the assessment

$623.2 million to resolve criminal charges and civil claims
S8 Tier A US Department of Justice, Medical Equipment Company Will Pay $646 Million for Making Illegal Payments to Doctors and Hospitals in United States and Latin America, 1 March 2016
Olympus Latin America admitted to bribing publicly employed health care providers.
S8 Tier A US Department of Justice, Medical Equipment Company Will Pay $646 Million for Making Illegal Payments to Doctors and Hospitals in United States and Latin America, 1 March 2016
three-year deferred prosecution agreement (DPA)
S8 Tier A US Department of Justice, Medical Equipment Company Will Pay $646 Million for Making Illegal Payments to Doctors and Hospitals in United States and Latin America, 1 March 2016

Conflicting or limiting record

No record located that conflicts with this assessment.

Evidence score: 82 of 100

The score grades how well the record establishes this assessment. It is not a score of Olympus Corporation. Score = source authority + directness + corroboration + procedural accuracy + currency + reproducibility.

ComponentPointsMaxReason
Source authorityIs the source competent to establish the proposition?2930A Justice Department release is a competent record of the charges and terms.
DirectnessDoes the source state the proposition or only discuss adjacent facts?1920The release states the amounts and the agreements directly.
CorroborationDo independent records support the same material point?815Only the department's release was read.
Procedural accuracyDoes the record settle the procedural state the claim describes?1115The agreements are settled terms, but not convictions.
CurrencyHas the record been checked against later developments?610The end of the three-year terms was not checked in court filings.
ReproducibilityCan a reader locate the passage and repeat the assessment?910The release is public in the justice.gov archive.
Total82100

Timeline

  1. DOJ announces the agreements and payments of about US$646 millionS8

Related cases

Revision history

  • Assessment first published with label Supported.

Have a record that changes this assessment? See corrections and responses.

Sources

  1. S8Tier A Medical Equipment Company Will Pay $646 Million for Making Illegal Payments to Doctors and Hospitals in United States and Latin AmericaUS Department of Justice. Regulator press release. 1 March 2016.Supports the charges, the deferred prosecution agreements and the amounts for the two US subsidiaries. It does not cover the Tokyo parent or later disposition.Link working, checked 25 October 2026

Other claims about Olympus Corporation